Yüklüyor......
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
BACKGROUND: We investigated the effect of cholinesterase inhibitors on all-cause discontinuation, efficacy and safety, and the effects of study design-, intervention-, and patient-related covariates on the risk-benefit of cholinesterase inhibitors for Alzheimer’s disease. METHODS: A systematic revie...
Kaydedildi:
| Yayımlandı: | Int J Neuropsychopharmacol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5492783/ https://ncbi.nlm.nih.gov/pubmed/28201726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyx012 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|